1. Moxley RT, III, Ashwal S, Pandya S, et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society 2005;64: 13–20.
2. Fitch K, Bernstein SJ, Aguilar MS, et al. The RAND/UCLA Appropriateness Method User’s Manual. Santa Monica, CA. RAND Corp, 2001.
3. Griggs RC, Moxley RT 3rd, Mendell JR, et al. Prednisone in Duchenne dystrophy: a randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol 1991;48: 383–388.
4. Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne’s muscular dystrophy. New Engl J Med 1989;320: 1592–1597.
5. Manzur AY, Kukntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy (Review). The Cochrane Library 2006:1–41.